|
US7632955B2
(en)
|
2001-12-13 |
2009-12-15 |
National Health Research Institutes |
Indole compounds
|
|
US7528165B2
(en)
|
2001-12-13 |
2009-05-05 |
National Health Research Institutes |
Indole compounds
|
|
PT1696920E
(pt)
|
2003-12-19 |
2015-01-14 |
Plexxikon Inc |
Compostos e métodos para o desenvolvimento de moduladores de ret
|
|
CN101676285A
(zh)
*
|
2004-03-30 |
2010-03-24 |
沃泰克斯药物股份有限公司 |
用作jak和其它蛋白激酶抑制剂的氮杂吲哚
|
|
US7498342B2
(en)
|
2004-06-17 |
2009-03-03 |
Plexxikon, Inc. |
Compounds modulating c-kit activity
|
|
JP2008508304A
(ja)
|
2004-07-27 |
2008-03-21 |
エスジーエックス ファーマシューティカルズ、インコーポレイテッド |
縮合環ヘテロ環キナーゼ調節因子
|
|
JP2008508303A
(ja)
|
2004-07-27 |
2008-03-21 |
エスジーエックス ファーマシューティカルズ、インコーポレイテッド |
ピロロ−ピリジンキナーゼモジュレーター
|
|
US7626021B2
(en)
*
|
2004-07-27 |
2009-12-01 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
US7361764B2
(en)
*
|
2004-07-27 |
2008-04-22 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
|
US7709645B2
(en)
*
|
2004-07-27 |
2010-05-04 |
Sgx Pharmaceuticals, Inc. |
Pyrrolo-pyridine kinase modulators
|
|
EP1828180A4
(en)
*
|
2004-12-08 |
2010-09-15 |
Glaxosmithkline Llc |
1H-pyrrolo [2,3-BETA] PYRIDINE
|
|
US7456289B2
(en)
|
2004-12-31 |
2008-11-25 |
National Health Research Institutes |
Anti-tumor compounds
|
|
PT2332909E
(pt)
|
2005-04-13 |
2014-12-17 |
Astex Therapeutics Ltd |
Derivados de hidroxibenzamida e sua utilização como inibidores de hsp90
|
|
CA2608733A1
(en)
|
2005-05-17 |
2007-02-01 |
Plexxikon, Inc. |
Pyrrol (2,3-b) pyridine derivatives protein kinase inhibitors
|
|
EP2395004B1
(en)
|
2005-06-22 |
2016-01-20 |
Plexxikon Inc. |
Pyrrolo [2,3-b]pyridine derivatives as protein kinase inhibitors
|
|
US8119655B2
(en)
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
|
UA95940C2
(uk)
|
2006-01-17 |
2011-09-26 |
Вертекс Фармасьютикалс Інкорпорейтед |
Азаіндоли як інгібітори кіназ януса
|
|
US7754725B2
(en)
|
2006-03-01 |
2010-07-13 |
Astex Therapeutics Ltd. |
Dihydroxyphenyl isoindolymethanones
|
|
DE102006012617A1
(de)
*
|
2006-03-20 |
2007-09-27 |
Merck Patent Gmbh |
4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
|
WO2007136790A2
(en)
*
|
2006-05-18 |
2007-11-29 |
Mannkind Corporation |
Intracellular kinase inhibitors
|
|
US20070286864A1
(en)
*
|
2006-06-09 |
2007-12-13 |
Buck Elizabeth A |
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors
|
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
PE20121506A1
(es)
|
2006-07-14 |
2012-11-26 |
Amgen Inc |
Compuestos triazolopiridinas como inhibidores de c-met
|
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
US20080242694A1
(en)
*
|
2006-09-18 |
2008-10-02 |
D Sidocky Neil R |
Amino-substituted heterocycles, compositions thereof, and methods of treatment therewith
|
|
EA200970361A1
(ru)
|
2006-10-09 |
2010-02-26 |
Такеда Фармасьютикал Компани Лимитед |
Ингибиторы киназы
|
|
JO3598B1
(ar)
*
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
الاحماض والاسترات البورونية كمثبطات اميد هيدروليز الحامض الدهني
|
|
EP2073802A1
(en)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
JP5518478B2
(ja)
|
2006-10-12 |
2014-06-11 |
アステックス、セラピューティックス、リミテッド |
医薬化合物
|
|
JP5528806B2
(ja)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
|
EP2073807A1
(en)
*
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
GB0620259D0
(en)
|
2006-10-12 |
2006-11-22 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
CN101568540A
(zh)
*
|
2006-11-01 |
2009-10-28 |
沃泰克斯药物股份有限公司 |
用作janus激酶抑制剂的三环杂芳基化合物
|
|
WO2008060907A2
(en)
|
2006-11-10 |
2008-05-22 |
Bristol-Myers Squibb Company |
Pyrrolo-pyridine kinase inhibitors
|
|
WO2008063888A2
(en)
|
2006-11-22 |
2008-05-29 |
Plexxikon, Inc. |
Compounds modulating c-fms and/or c-kit activity and uses therefor
|
|
MY188335A
(en)
|
2006-11-22 |
2021-11-30 |
Incyte Holdings Corp |
Imidazotriazines and imidazopyrimidines as kinase inhibitors
|
|
EP2094701A2
(en)
*
|
2006-12-21 |
2009-09-02 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
PE20081581A1
(es)
*
|
2006-12-21 |
2008-11-12 |
Plexxikon Inc |
COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
|
|
CA2673472A1
(en)
|
2006-12-21 |
2008-07-03 |
Vertex Pharmaceuticals Incorporated |
5-cyan0-4- (pyrrolo) [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
|
WO2008079909A1
(en)
|
2006-12-21 |
2008-07-03 |
Plexxikon, Inc. |
Pyrrolo [2,3-b] pyridines as kinase modulators
|
|
CA2677096A1
(en)
*
|
2007-01-31 |
2008-08-07 |
Vertex Pharmaceuticals Incorporated |
Kinase inhibitors
|
|
GB0702259D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-azaindole derivatives
|
|
GB0702265D0
(en)
*
|
2007-02-06 |
2007-03-14 |
Eisai London Res Lab Ltd |
7-Azaindole derivatives
|
|
US8242280B2
(en)
|
2007-04-10 |
2012-08-14 |
Sgx Pharmaceuticals, Inc. |
Fused ring heterocycle kinase modulators
|
|
US8263585B2
(en)
*
|
2007-05-04 |
2012-09-11 |
Novartis Ag |
Organic compounds
|
|
CA2688823A1
(en)
*
|
2007-05-21 |
2008-11-27 |
Sgx Pharmaceuticals, Inc. |
Heterocyclic kinase modulators
|
|
DE102007028515A1
(de)
*
|
2007-06-21 |
2008-12-24 |
Merck Patent Gmbh |
6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate
|
|
EA201070233A1
(ru)
*
|
2007-07-06 |
2010-08-30 |
Паратек Фармасьютикалс, Инк. |
Способы синтеза замещённых соединений тетрациклина (варианты)
|
|
CA2695004C
(en)
|
2007-07-17 |
2016-01-19 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
WO2009013348A2
(en)
*
|
2007-07-26 |
2009-01-29 |
Novartis Ag |
Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
|
|
US8183245B2
(en)
*
|
2007-10-25 |
2012-05-22 |
Merck Sharp & Dohme Corp. |
Pyrazine substituted pyrrolopyridines as inhibitors of JAK and PDK1
|
|
US8598165B2
(en)
|
2007-11-26 |
2013-12-03 |
University Of Kansas |
Morpholines as selective inhibitors of cytochrome P450 2A13
|
|
US8268834B2
(en)
*
|
2008-03-19 |
2012-09-18 |
Novartis Ag |
Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
|
|
GB0806527D0
(en)
|
2008-04-11 |
2008-05-14 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
|
BRPI0912882A2
(pt)
|
2008-05-21 |
2017-05-16 |
Incyte Corp |
sais de 2-flúor-n-metil-4-[7-(quinolin-6-il-metil)-imidazo[1,2-b][1,2,4]triazin-2-il]benzamida e processos relacionados à preparação dos mesmos
|
|
US8569337B2
(en)
|
2008-07-23 |
2013-10-29 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
EP2328896B1
(en)
|
2008-07-23 |
2013-10-23 |
Vertex Pharmaceuticals Incorporated |
Tri-cyclic pyrazolopyridine kinase inhibitors
|
|
MX2011000839A
(es)
|
2008-07-23 |
2011-04-05 |
Vertex Pharma |
Inhibidores de pirazolpiridina cinasa.
|
|
RU2478636C2
(ru)
|
2008-08-05 |
2013-04-10 |
Дайити Санкио Компани, Лимитед |
ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДИН-2-ОНА, ОБЛАДАЮЩИЕ mTOR ИНГИБИРУЮЩЕЙ АКТИВНОСТЬЮ
|
|
MX2011001370A
(es)
*
|
2008-08-05 |
2011-03-15 |
Abbott Lab |
Compuestos utiles como inhibidores de cinasas de proteina.
|
|
JP2011530527A
(ja)
|
2008-08-06 |
2011-12-22 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
アミノピリジンキナーゼ阻害剤
|
|
CA2744498C
(en)
*
|
2008-11-25 |
2017-10-24 |
University Of Rochester |
Mlk inhibitors and methods of use
|
|
JOP20190231A1
(ar)
*
|
2009-01-15 |
2017-06-16 |
Incyte Corp |
طرق لاصلاح مثبطات انزيم jak و المركبات الوسيطة المتعلقة به
|
|
FR2941948B1
(fr)
|
2009-02-12 |
2013-04-05 |
Nova Decision |
Derives d'azaindoles en tant qu'inhibiteur des proteines kinases abl et src
|
|
MX349923B
(es)
*
|
2009-04-03 |
2017-08-21 |
Hoffmann La Roche |
Composiciones del ácido propano-1-sulfónico {3-[5-(4-cloro-fenil)- 1h-pirrolo [2,3-b]-piridina-3-carbonil]-2,4-difluoro-fenil]-amida y el uso de las mismas.
|
|
CN102459259A
(zh)
|
2009-05-06 |
2012-05-16 |
沃泰克斯药物股份有限公司 |
吡唑并吡啶类
|
|
BRPI1011993A2
(pt)
|
2009-06-17 |
2021-07-06 |
Vertex Pharmaceuticals Incorporated |
inibidores de replicação do vírus influenza, seu uso, método de preparação dos mesmos e compositção farmacêutica que os compreende
|
|
US8703808B2
(en)
|
2009-06-23 |
2014-04-22 |
Centre National De La Recherche Scientifique |
Use of derivatives of indoles for the treatment of cancer
|
|
EP2266562A1
(en)
*
|
2009-06-23 |
2010-12-29 |
Centre National de la Recherche Scientifique |
Use of derivatives of indoles for the treatment of cancer
|
|
US8329724B2
(en)
|
2009-08-03 |
2012-12-11 |
Hoffmann-La Roche Inc. |
Process for the manufacture of pharmaceutically active compounds
|
|
GB0918924D0
(en)
*
|
2009-10-28 |
2009-12-16 |
Vantia Ltd |
Azaindole derivatives
|
|
ES2633317T3
(es)
|
2009-11-06 |
2017-09-20 |
Plexxikon, Inc. |
Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
|
|
RS63612B1
(sr)
|
2009-12-31 |
2022-10-31 |
Hutchison Medipharma Ltd |
Neki triazolopirazini, njihove kompozicije i postupci njihovog korišćenja
|
|
CA2787315A1
(en)
|
2010-01-27 |
2011-08-04 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyridine kinase inhibitors
|
|
AU2011209651A1
(en)
|
2010-01-27 |
2012-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazolopyrimidine kinase inhibitors
|
|
CN102869663A
(zh)
|
2010-01-27 |
2013-01-09 |
沃泰克斯药物股份有限公司 |
吡唑并吡嗪激酶抑制剂
|
|
CA2788587C
(en)
*
|
2010-02-03 |
2020-03-10 |
Infinity Pharmaceuticals, Inc. |
Fatty acid amide hydrolase inhibitors
|
|
ES2488219T3
(es)
*
|
2010-04-19 |
2014-08-26 |
Abbvie Inc. |
Pirrolopiridinas como inhibidores de quinasas
|
|
CA2797281A1
(en)
*
|
2010-05-06 |
2011-11-10 |
Merck Sharp & Dohme Corp. |
Aza-indole derivatives useful as modulators of faah
|
|
EP2576549A4
(en)
|
2010-05-24 |
2013-12-18 |
Univ Rochester |
BICYCLIC HETEROARYLATES FORMING KINASE INHIBITORS AND METHODS OF USE
|
|
US8779150B2
(en)
*
|
2010-07-21 |
2014-07-15 |
Hoffmann-La Roche Inc. |
Processes for the manufacture of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1 H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide
|
|
CN103492381A
(zh)
|
2010-12-16 |
2014-01-01 |
沃泰克斯药物股份有限公司 |
流感病毒复制的抑制剂
|
|
TR201816421T4
(tr)
|
2011-02-07 |
2018-11-21 |
Plexxikon Inc |
Kinaz modülasyonu için bileşikler ve metotlar ve bunların endikasyonları.
|
|
TWI558702B
(zh)
|
2011-02-21 |
2016-11-21 |
普雷辛肯公司 |
醫藥活性物質的固態形式
|
|
US8791112B2
(en)
|
2011-03-30 |
2014-07-29 |
Arrien Pharmaceuticals Llc |
Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-B] pyridine and pyrazolo [3, 4-B] pyridine derivatives as protein kinase inhibitors
|
|
RU2631487C2
(ru)
|
2011-05-17 |
2017-09-22 |
Плексксикон Инк. |
Модуляция киназ и показания к её применению
|
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
WO2013052355A1
(en)
|
2011-10-03 |
2013-04-11 |
Merck Sharp & Dohme Corp. |
Azaindoles as janus kinase inhibitors
|
|
DE102011119127A1
(de)
|
2011-11-22 |
2013-05-23 |
Merck Patent Gmbh |
3-Cyanaryl-1H-pyrrolo[2.3-b]pyridin-Derivate
|
|
US9358235B2
(en)
|
2012-03-19 |
2016-06-07 |
Plexxikon Inc. |
Kinase modulation, and indications therefor
|
|
US9150570B2
(en)
|
2012-05-31 |
2015-10-06 |
Plexxikon Inc. |
Synthesis of heterocyclic compounds
|
|
CN104884059B
(zh)
|
2012-11-30 |
2018-08-10 |
罗切斯特大学 |
用于hiv/aids治疗的混合谱系激酶抑制剂
|
|
US9260426B2
(en)
*
|
2012-12-14 |
2016-02-16 |
Arrien Pharmaceuticals Llc |
Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors
|
|
US20140303121A1
(en)
|
2013-03-15 |
2014-10-09 |
Plexxikon Inc. |
Heterocyclic compounds and uses thereof
|
|
PT2970265T
(pt)
*
|
2013-03-15 |
2018-10-23 |
Plexxikon Inc |
Compostos heterocíclicos e suas utilizações
|
|
US9206188B2
(en)
|
2013-04-18 |
2015-12-08 |
Arrien Pharmaceuticals Llc |
Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitors
|
|
CN104119331B
(zh)
*
|
2013-04-26 |
2018-02-06 |
广东东阳光药业有限公司 |
烯基化合物及其使用方法和用途
|
|
GB2515785A
(en)
*
|
2013-07-03 |
2015-01-07 |
Redx Pharma Ltd |
Compounds
|
|
WO2015073481A1
(en)
|
2013-11-13 |
2015-05-21 |
Vertex Pharmaceuticals Incorporated |
Methods of preparing inhibitors of influenza viruses replication
|
|
PT3068776T
(pt)
|
2013-11-13 |
2019-08-26 |
Vertex Pharma |
Inibidores da replicação de vírus da gripe
|
|
MX2017009571A
(es)
*
|
2015-01-23 |
2018-09-27 |
Aclaris Therapeutics Inc |
Inhibidores heterociclicos de itk para el tratamiento de la inflamacion y cancer.
|
|
KR101660863B1
(ko)
*
|
2015-04-03 |
2016-09-28 |
주식회사 녹십자 |
IKKε 및 TBK1 억제제로서의 7-아자인돌 또는 4,7-다이아자인돌 유도체 및 이를 포함하는 약학적 조성물
|
|
US10160755B2
(en)
*
|
2015-04-08 |
2018-12-25 |
Plexxikon Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
|
EP3294717B1
(en)
|
2015-05-13 |
2020-07-29 |
Vertex Pharmaceuticals Inc. |
Methods of preparing inhibitors of influenza viruses replication
|
|
MA42422A
(fr)
|
2015-05-13 |
2018-05-23 |
Vertex Pharma |
Inhibiteurs de la réplication des virus de la grippe
|
|
EP3383875B1
(en)
*
|
2015-11-30 |
2022-02-09 |
Council Of Scientific & Industrial Research |
3-pyrimidinyl pyrrolo [2,3-b] pyridine as anticancer agents and the process for the preparation thereof
|
|
BR112018011475A2
(pt)
|
2015-12-07 |
2018-12-04 |
Plexxikon Inc |
compostos e métodos para modulação de quinase e indicação para a mesma
|
|
WO2018217766A1
(en)
|
2017-05-22 |
2018-11-29 |
Whitehead Institute For Biomedical Research |
Kcc2 expression enhancing compounds and uses thereof
|
|
WO2018226846A1
(en)
|
2017-06-07 |
2018-12-13 |
Plexxikon Inc. |
Compounds and methods for kinase modulation
|
|
CN107550905B
(zh)
*
|
2017-09-11 |
2020-07-17 |
浙江永宁药业股份有限公司 |
多取代吡咯并吡啶类化合物的药物用途及其制备方法
|
|
WO2019057660A1
(en)
*
|
2017-09-25 |
2019-03-28 |
Basf Se |
INDOLE AND AZAINDOLE COMPOUNDS HAVING 6-CHANNEL SUBSTITUTED ARYL AND HETEROARYL CYCLES AS AGROCHEMICAL FUNGICIDES
|
|
AU2018348241B2
(en)
|
2017-10-13 |
2023-01-12 |
Opna Bio SA |
Solid forms of a compound for modulating kinases
|
|
CA3092828A1
(en)
*
|
2018-03-01 |
2019-09-06 |
The Trustees Of Columbia University In The City Of New York |
Compounds, compositions, and methods for suppressing toxic endoplasmic reticulum stress
|
|
TW202039483A
(zh)
*
|
2018-11-22 |
2020-11-01 |
英屬開曼群島商百濟神州有限公司 |
作為HPK1抑制劑的吡咯並[2,3-b]吡啶以及它們的用途
|
|
AU2020271836B2
(en)
*
|
2019-04-09 |
2025-11-13 |
Opna Bio SA |
Condensed azines for EP300 or CBP modulation and indications therefor
|
|
TWI848141B
(zh)
|
2019-07-04 |
2024-07-11 |
英屬開曼群島商百濟神州有限公司 |
及其用途
|
|
CN112239473B
(zh)
|
2019-07-17 |
2023-12-08 |
百济神州(北京)生物科技有限公司 |
作为hpk1抑制剂的三环化合物的制备方法
|
|
JP7564888B2
(ja)
|
2020-05-01 |
2024-10-09 |
ギリアード サイエンシーズ， インコーポレイテッド |
Ｃｄ７３阻害性２，４－ジオキソピリミジン化合物
|
|
JP2023545219A
(ja)
*
|
2020-10-05 |
2023-10-26 |
エンライブン インコーポレイテッド |
Ｂｃｒ－ａｂｌチロシンキナーゼの阻害のための７－アザインドール化合物
|
|
US20240239795A1
(en)
*
|
2021-05-21 |
2024-07-18 |
Centre National De La Recherche Scientifique |
Novel azaindole derivatives as antiviral agents
|
|
WO2023245329A1
(en)
*
|
2022-06-20 |
2023-12-28 |
Biofront Ltd |
Multi-kinase inhibitors, compositions thereof, and methods of using the same
|
|
WO2023245327A1
(en)
*
|
2022-06-20 |
2023-12-28 |
Biofront Ltd |
Multiple kinase degraders, compositions comprising the degrader, and methods of using the same
|